Hyskon Interactions
There are 32 drugs known to interact with Hyskon (dextran, high molecular weight), along with 4 disease interactions. Of the total drug interactions, 24 are major, and 8 are moderate.
- View all 32 medications that may interact with Hyskon
- View Hyskon disease interactions (4)
Most frequently checked interactions
View interaction reports for Hyskon (dextran, high molecular weight) and the medicines listed below.
- Albutein (albumin human)
- Aller-Chlor (chlorpheniramine)
- Alphanate (antihemophilic factor/von willebrand factor)
- amiodarone
- anagrelide
- bedaquiline
- Bevyxxa (betrixaban)
- Brilinta (ticagrelor)
- Cablivi (caplacizumab)
- Celontin (methsuximide)
- Corlopam (fenoldopam)
- Dextran 40 (dextran, low molecular weight)
- Dilantin (phenytoin)
- Fentora (fentanyl)
- Flebogamma (immune globulin intravenous)
- GamaSTAN S/D (immune globulin intramuscular)
- Jantoven (warfarin)
- M-M-R II (measles virus vaccine / mumps virus vaccine / rubella virus vaccine)
- Mebaral (mephobarbital)
- Mesantoin (mephenytoin)
- Milontin (phensuximide)
- Mysoline (primidone)
- Orap (pimozide)
- Paradione (paramethadione)
- Peganone (ethotoin)
- Phenabid DM (chlorpheniramine / dextromethorphan / phenylephrine)
- phenobarbital
- Phenurone (phenacemide)
- Propulsid (cisapride)
- Rexulti (brexpiprazole)
Hyskon disease interactions
There are 4 disease interactions with Hyskon (dextran, high molecular weight) which include:
Report options
QR code containing a link to this page
More about Hyskon (dextran, high molecular weight)
- Hyskon consumer information
- Compare alternatives
- Side effects
- Drug class: plasma expanders
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.